ConductScience.org, home

Paper593972

Soluble biomedical polymers.

Kopecek J. Polim Med, 1977. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Soluble biomedical polymers. Papers, record 593972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/593972

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Soluble biomedical polymers.
PubMed
Journal
Polim Med
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.3
iCite
Revised in PubMed
2008-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kopecek JJ

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PolymersMajor topic
Anti-Bacterial Agents
Antitubercular Agents
Biocompatible Materials
Chemical Phenomena
Chemistry
Humans
Solubility

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
38734315Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics.J Control Release2024https://conductscience.org/library/papers/38734315PubMed
37849670Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy.BME Front2023https://conductscience.org/library/papers/37849670PubMed
32735811Polymer nanomedicines.Adv Drug Deliv Rev2020https://conductscience.org/library/papers/32735811PubMed
29966420Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis.Mol Pharm2018https://conductscience.org/library/papers/29966420PubMed
29313017Anticancer nanoparticulate polymer-drug conjugate.Bioeng Transl Med2016https://conductscience.org/library/papers/29313017PubMed
29276426The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.Curr Opin Colloid Interface Sci2017https://conductscience.org/library/papers/29276426PubMed
28830983HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer.Mol Cancer Ther2017https://conductscience.org/library/papers/28830983PubMed
28094954Backbone Degradable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts.Mol Pharm2017https://conductscience.org/library/papers/28094954PubMed
26688694POLYMERIC BIOMATERIALS AND NANOMEDICINES.J Drug Deliv Sci Technol2015https://conductscience.org/library/papers/26688694PubMed
26437260Design of smart HPMA copolymer-based nanomedicines.J Control Release2016https://conductscience.org/library/papers/26437260PubMed
26191406Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.Biomater Sci2015https://conductscience.org/library/papers/26191406PubMed
25709446Nanopharmaceuticals (part 2): products in the pipeline.Int J Nanomedicine2015https://conductscience.org/library/papers/25709446PubMed
24747162Macromolecular therapeutics.J Control Release2014https://conductscience.org/library/papers/24747162PubMed
23827653Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.Int J Pharm2013https://conductscience.org/library/papers/23827653PubMed
23731780Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats.Biomaterials2013https://conductscience.org/library/papers/23731780PubMed
23339052Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy.Macromol Biosci2013https://conductscience.org/library/papers/23339052PubMed
23123294Polymer-drug conjugates: origins, progress to date and future directions.Adv Drug Deliv Rev2013https://conductscience.org/library/papers/23123294PubMed
22493797Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.Macromol Biosci2012https://conductscience.org/library/papers/22493797PubMed
22288884Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.Biomacromolecules2012https://conductscience.org/library/papers/22288884PubMed
21499527Synthesis of Biodegradable Multiblock Copolymers by Click Coupling of RAFT-Generated HeterotelechelicPolyHPMA Conjugates.React Funct Polym2011https://conductscience.org/library/papers/21499527PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/593972

GET https://conductscience.org/api/papers/v1/593972/cited_by?page=2